This website is intended for patients & providers in the USA only. Prescribing Information.
This website is intended for patients & providers outside of the USA. Prescribing Information.

September 04, 2019

Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence Society Annual Meeting

StimRouter helping improve lives of patients in Europe and Australia beyond the management of chronic pain

Continue Reading

February 18, 2019

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

StimRouter now available in Europe beyond the management of chronic pain

Continue Reading